Lab Testing Transparency will Improve Patient Care and Lower Costs

In the news

Avalon’s CEO Bill Kerr, M.D., shares in a MedCity News article why lab testing price transparency and payment integrity programs should be priorities as the U.S. healthcare industry
continues to advance value-based care and population health.

Read more by visiting MedCityNews.

bill kerr headshot

Special Policy Session: Exploring the Impact of Electronic Prior Authorization (ePA) Proposed Rule

Wednesday, February 15
1 – 2 p.m. EDT

Connect With Us

Want to get in touch? We’d love to hear from you.